Form 8-K - Current report:
SEC Accession No. 0000950135-08-004752
Filing Date
2008-07-01
Accepted
2008-07-01 08:48:16
Documents
5
Period of Report
2008-06-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BENTLEY PHARMACEUTICALS, INC. b70695bpe8vk.htm 8-K 17272
2 EX-99.1 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION b70695bpexv99w1.htm EX-99.1 130300
3 EX-99.2 PRESS RELEASE, DATED JULY 1, 2008 b70695bpexv99w2.htm EX-99.2 10417
4 GRAPHIC b70695bpb7069501.gif GRAPHIC 6522
5 GRAPHIC b70695bpb7069502.gif GRAPHIC 1748
  Complete submission text file 0000950135-08-004752.txt   171327
Mailing Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833
Business Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 6036586100
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10581 | Film No.: 08927755
SIC: 2834 Pharmaceutical Preparations